Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res. 2009 Dec 1;69(23):8894-901. doi: 10.1158/0008-5472.CAN-09-1152. Epub 2009 Nov 17.

Hypoxia regulates insulin receptor substrate-2 expression to promote breast carcinoma cell survival and invasion.

Author information

1
Department of Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusett 01605, USA.

Abstract

Insulin receptor substrate-2 (IRS-2) belongs to the IRS family of adaptor proteins that function as signaling intermediates for growth factor, cytokine, and integrin receptors, many of which have been implicated in cancer. Although the IRS proteins share significant homology, distinct functions have been attributed to each family member in both normal and tumor cells. In cancer, IRS-2 is positively associated with aggressive tumor behavior. In the current study, we show that IRS-2 expression, but not IRS-1 expression, is positively regulated by hypoxia, which selects for tumor cells with increased metastatic potential. We identify IRS-2 as a novel hypoxia-responsive gene and establish that IRS-2 gene transcription increases in a hypoxia-inducible factor-dependent manner in hypoxic environments. IRS-2 is active to mediate insulin-like growth factor I-dependent signals in hypoxia, and enhanced activation of Akt in hypoxia is dependent on IRS-2 expression. Functionally, the elevated expression of IRS-2 facilitates breast carcinoma cell survival and invasion in hypoxia. Collectively, our results reveal a novel mechanism by which IRS-2 contributes to the aggressive behavior of hypoxic tumor cells.

PMID:
19920186
PMCID:
PMC2789198
DOI:
10.1158/0008-5472.CAN-09-1152
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center